-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster II

Symposia: Myeloproliferative Syndromes: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Deepti H. Radia, MD1*, Tsewang Tashi, MD, PhD2*, Ivan Alvarez-Twose, MD, PhD3*, Patrizia Bonadonna, MD4*, Hanneke Oude Elberink, MD, PhD5*, Sonia Cerquozzi, MD6, Tracy I. George, MD7,8, Guang Yang, PhD9, Mark Rosenzweig, PhD9*, Hui-Min Lin, PhD9*, Ben Lampson, MD, PhD9*, Rachel L. Erlich, PhD9* and Jason Gotlib, MD, MS10

1Guy’s Hospital London, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
2Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
3Spanish Reference Center of Mastocytosis, Institute of Mastocytosis Studies of Castilla-La Mancha, Toledo, Spain
4Department of Medicine, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy
5Department of Allergology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
6Division of Hematology and Hematologic Malignancies, University of Calgary, Calgary, Canada
7ARUP Laboratories, University of Utah, Salt Lake City, UT
8Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
9Blueprint Medicines Corporation, Cambridge, MA
10Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA

Yi Zhang1*, Hu Zhou2, Shanshan Suo, MD1*, Junling Zhuang, MD, PhD3, Linhua Yang, MD4*, Aili He, PhD, MD5*, Qingchi Liu6*, Xin Du, PhD7, Sujun Gao8*, Yarong Li9*, Yan Li10*, Yuqing Chen11*, Wen Wu12*, Huanling Zhu13*, Guangsheng He14*, Mei Hong, MD15*, Qian Jiang, MD16, Zhongxing Jiang17*, Hongmei Jing18, Jishi Wang, PhD19, Na Xu20*, Lingling Yue21*, Cuiping Zheng22*, ZePing Zhou, MD, PhD23, Chenghao Jin24*, Xin Li25*, Lin Liu26*, Yajing Xu, MD27*, Dengshu Wu28*, Feng Zhang29*, Jin Zhang30*, Zhijian Xiao, MD31* and Jie Jin, M.D.32

1Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Department of Hematology, Henan Provincial Cancer Hospital, Zhengzhou, China
3Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China
4The Second Hospital of Shanxi Medical University, Taiyuan, China
5Department of Hematology, The Second Affiliated Hospital of Xi’an Jiao Tong University, Xi'an Key Laboratory of Hematological Diseases, Xi’an, China
6The First Hospital of Hebei Medical University, Shijiazhuang, China
7Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, WA, China
8Department of Hematology, The First Hospital of Jilin University, Changchun, China
9Department of Hematology and Oncology, The Second Hospital of Jilin University, Changchun, CHN
10Department of Hematopathology, The First Affiliated Hospital of China Medical University, Shenyang, China
11Department of Hematology, Henan Province People's Hospital, Zhengzhou, China
12Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
13Department of Hematology, West China Hospital, Sichuan University, Chengdu, China
14The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Key Laboratory of Hematology of Nanjing Medical University, Collaborative Innovation Center for Cancer Personalize, Nanjing, China
15Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
16National Clinical Research Center for Hematologic Disease, Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, Beijing, China
17The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
18Peking University Third Hospital, Beijing, CHN
19Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang City, China
20Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
21Department of Hematology and Oncology, Lanzhou University Second Hospital, Lanzhou, China
22Second Department of Oncology, Wenzhou Central Hospital, Wenzhou, China
23Second Affiliated Hospital of Kunming Medical University, Kunming, China
24Jiangxi Provincial People's Hospital, Nanchang, China
25Department of Hematology, Third Xiangya Hospital of Central South University, Changsha, China
26Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
27Xiangya Hospital, Central South University, Changsha, Hunan, China
28Department of Hematology, Xiangya Hospital, Central South University, Changsha, China
29Department of Hematology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China
30Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
31MDS and MPN Centre, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
32Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

He Lin1*, Xin-xin Cao1*, Long Chang1*, Min Lang1*, Zheng-Zheng Liu1*, Minghui Duan1*, Daobin Zhou, MD2* and Wen Gao3

1Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
2Department of Hematology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China
3Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China

Corentin Orvain1*, Suzanne Tavitian, MD2*, Clemence Mediavilla, MD3*, Francoise Boyer, MD4*, Alberto Santagostino5*, Geoffroy Venton6*, Samia Madene7*, Tony Marchand, MD, PhD8*, Pascal Turlure, MD9*, Diane Lara10*, Lenaïg Le Clech11*, Katell Le Du12*, Jean-Baptiste Robin13*, Lise Willems14*, Anaise Blouet15*, Thomas Systchenko16*, Mathieu Wemeau, MD17*, Hélène Pasquer, M.D.18*, Melanie Mercier19*, Christophe Nicol20*, Laurence Legros, MD, PhD21*, Antoine Machet, MD22*, Franck E. Nicolini, MD, PhD23, Lydia Roy, MD24*, Clémentine Salvado25*, Guillaume Denis26*, Elsa Lestang27*, Kamel Laribi28*, Eric Lippert29*, Lina Benajiba, MD, PhD30 and Jean-Christophe Ianotto, MD, PhD, HDR31*

1Hematology Clinic, Angers University Hospital, Angers, France
2Department of Hematology, Toulouse University Cancer Institute Oncopole, Toulouse University Hospital, Toulouse, France
3Hematology Department, CHU de Bordeaux, Bordeaux, France
4Department of Hematology, Angers University Hospital, Angers, France
5Service d’Hématologie Clinique, Centre Hospitalier de Troyes, Troyes, France
6Hôpital de la Timone, Service Hématologie et Thérapie Cellulaire, Centre d’Essais Précoces en Cancérologie de Marseille (CEPCM), Marseille, France
7CH Mont -de-Marsan, Mont-de-Marsan, FRA
8Hematology Clinic, Rennes University Hospital, Rennes, France
9Service d'Hématologie Clinique, CHU de Limoges, Limoges, France
10Centre Hospitalier de Libourne, Libourne, France
11Centre Hospitalier De Cornouaille, Quimper, FRA
12Hôpital privé du Confluent, Nantes, FRA
13CH Bayonne, Bayonne, France
14Hôpital Cochin, PARIS, FRA
15Strasbourg Oncologie Libérale, Clinique Sainte-Anne, Strasbourg, France
16Poitiers University Hospital, Poitiers, France
17Department of Hematology, Roubaix Hospital, Roubaix, France
18St Louis Hospital, INSERM U944, PARIS, FRA
19Centre Hospitalier Bretagne Atlantique, Vannes, FRA
20Morlaix Hospital, Morlaix, France
21Service d’Hématologie-Clinique Ambulatoire (SHCA), APHP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France
22Tours University Hospital, Tours, France
23Hematology Department, Centre Leon Berard, LYON Cedex 03, France
24Hematology Department, Henri Mondor University Hospital, UPEC, IMRB, Assistance Publique Hopitaux de Paris, Créteil, France
25Dax Hospital, Dax, France
26Rochefort Hospital, Rochefort, France
27Saint Nazaire Hospital, Saint Nazaire, France
28Hématologie Clinique, CH Le Mans, Le Mans, France
29Brest University Hospital, Brest, France
30INSERM UMR944, Institut de Recherche Saint-Louis, Paris, France
31Hematology department, Centre Hospitalier Universitaire de Brest, Brest, France

Edouard Long1*, Roberta Dunn2*, Laura Li Gagnon, MD3*, Claire Harrison4, Yunfan Yang, MD3,5* and Jennifer O'Sullivan6*

1GKT School of Medical Education, King’s College London, London, ENG, United Kingdom
2GKT School of Medical Education, King's College London, London, United Kingdom
3Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom
4Department of Haematology, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
5Department of Hematology, West China Hospital of Sichuan University, Chengdu, China
6Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom

Ayalew Tefferi, MD1, Giuseppe Gaetano Gaetano Loscocco2*, Maymona Abdelmagid, MD3*, Animesh D. Pardanani, MBBS, PhD3, Kebede Begna, MD3, Mrinal M. Patnaik, MD, MBBS4, Natasha Szuber, MD, MSc5, Alessandra Carobbio6*, Tiziano Barbui, MD7*, Kaaren K. Reichard, MD8, Paola Guglielmelli, MD9, Naseema Gangat, MBBS1 and Alessandro M. Vannucchi, MD2

1Division of Hematology, Mayo Clinic, Rochester, MN
2CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
3Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
4Mayo Clinic, Rochester, MN
5Institut universitaire d'hématologie-oncologie et de thérapie cellulaire, Université de Montréal, Montreal, QC, Canada
6Fondazione per la Ricerca Ospedale di Bergamo (FROM), Bergamo, Italy
7FROM Research Foundation ASST Papa Giovanni XXIII Bergamo, Bergamo, ITA
8Department of Pathology, Mayo Clinic, Rochester, MN
9University of Florence, Firenze, Florence, ITA

Seug Yun Yoon1*, Jong-Ho Won, MD2, Sung-Eun Lee, MD, PhD3*, Sung-Soo Yoon, M.D., Ph.D.4, Deok-Hwan Yang, MD, PhD5*, Gyeong Won Lee6*, Sang Kyun Sohn, MD, PhD7*, Ho-Jin Shin, MD8*, Sung Hwa Bae, MD9*, Chul Won Choi10*, Yunsuk Choi, MD, PhD11, June-won Cheong, MD, PhD12, Soo-Mee Bang, MD, PhD13, Joon Seong Park, MD14*, Sukjoong Oh, MD15, Yong Park, MD, PhD16 and Young Hoon Park17*

1Division of Hematology & Medical Oncology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea, Republic of (South)
2Division of Hematology & Medical Oncology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, KOR
3Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Houston, TX
4Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
5Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of (South)
6Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea, Republic of (South)
7Department of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea, Republic of (South)
8Division of Hematology-Oncology, Department of Internal Medicine, Biochemical Research Institution, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea, Republic of (South)
9Department of Internal Medicine, Daegu Catholic, University Hospital, Daegu Catholic University School of Medicine, Daegu, KOR
10Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea, Republic of (South)
11Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
12Severance Hospital, Yonsei University College of Medicine, Seoul, KOR
13Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, Republic of (South)
14Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea, Republic of (South)
15Hanyang University Medical Center, Seoul, KOR
16Division of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea, Republic of (South)
17Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of (South)

Fnu Aperna, MBBS1*, Moazah Iftikhar, MBBS1*, Masooma S Rana, MBBS1*, Animesh D. Pardanani, MBBS, PhD1, Paola Guglielmelli, MD2, Alessandro Maria Vannucchi3, Naseema Gangat, MBBS4, Ayalew Tefferi, MD4 and Giuseppe Gaetano Loscocco1,3*

1Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
2Department of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Florence, Italy
3Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy
4Division of Hematology, Mayo Clinic, Rochester, MN

Alexander Gazda, MD1*, Di Pan, DO2*, Katie Erdos3*, Ghaith Abu-Zeinah, MD3, Alexandra Racanelli, MD, PhD2*, Evelyn Horn, MD4* and Joseph M. Scandura, MD, PhD3

1Division of Pulmonary and Critical Care, Department of Medicine, Weill Cornell Medical College, New York, NY
2Weill Cornell Medical College, New York, NY
3Richard T. Silver, MD Myeloproliferative Neoplasms Center, Weill Cornell Medicine, New York, NY
4Greenberg Cardiology Division, Department of Medicine, Weill Cornell Medical College, New York, NY

Resham Mawalkar, bsc1, Hua-Ling Tsai, Sc.M2*, Terra Marie M Jouaneh, MS1*, Shivam Patel, BS1*, Christopher Gocke, MD3*, Eitan Halper-Stromberg, MD, PhD4*, Rena R. Xian, MD5, K. C. Rappazzo, MD6*, Evan M. Braunstein, MD, PhD7, Alison R. Moliterno, MD8 and Tania Jain, MD9

1Johns Hopkins University School of Medicine, Baltimore, MD
2Division of Biostatistics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
3Johns Hopkins Medical Institutions, Baltimore, MD
4Director of Cancer Genetics Lab, Johns Hopkins University School of Medicine, Baltimore, MD
5Division of Hematopathology, Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD
6Division of Hematology, Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
7Johns Hopkins University, Baltimore, MD
8Division of Hematology, Department of Medicine, Johns Hopkins University/Fda, Silver Spring, MD
9Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD

Marion Divoux, MD1,2*, Ghislain Fievet3*, Natacha Dreumont, PhD3*, Laurence Schenone, MD4*, Maud D'Aveni, MD, PhD5*, Francois Girodon, MD, PhD6*, Pierre Feugier, MD, PhD2,4*, Sébastien Hergalant, PhD3* and Julien Broséus, MD, PhD4,7*

1UMR Inserm 1256 NGERE (Nutrition, Génétique et Exposition aux Risques Environnementaux), Université de Lorraine, Faculté de médecine, Vandoeuvre, France
2Department of Haematology, Centre Hospitalier Régional Universitaire (CHRU) de Nancy, Vandoeuvre-lès-Nancy, France
3UMR Inserm 1256 NGERE (Nutrition, Génétique et Exposition aux Risques Environnementaux), Université de Lorraine, Faculté de médecine, Vandoeuvre-lès-Nancy, France
4UMR Inserm 1256 NGERE (Nutrition, Génétique et Exposition aux Risques Environnementaux), Université de Lorraine, Faculté de médecine, vandoeuvre-lès-nancy, France
5Department of Haematology,, Centre Hospitalier Régional Universitaire (CHRU) de Nancy, Vandoeuvre-les-Nancy, France
6Laboratory of Biological Hematology, University Hospital of Dijon, Dijon, France
7Laboratory of Biological Hematology,, Centre Hospitalier Régional Universtaire de Nancy, vandoeuvre-lès-nancy, France

Yuhui Zhang1*, Guangshuai Teng1*, Yifan Duan1*, Chenxiao Du1*, Yan Wang1*, Huiqin Zhang1*, Xin Hu1*, Yunhan Zhao1*, Yuan Zhou2*, Weiping Yuan1,2 and Jie Bai, MD3

1Department of Hematology, the Second Hospital of Tianjin Medical University, Tianjin, China
2State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
3Institute of Hematology &blood Disease Hospital, Tianjin City, Tianjin City, China

Moazah Iftikhar, MBBS1*, Masooma S Rana, MBBS1*, Yamna Jadoon, MBBS2, Maymona Abdelmagid, MD1*, Kaaren K. Reichard, MD3, Cinthya Zepeda Mendoza, PhD4*, Animesh D. Pardanani, MBBS, PhD1, Ayalew Tefferi, MD5 and Naseema Gangat, MBBS5

1Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
2UMass Chan Medical School Baystate, Broad Brook, CT
3Department of Pathology, Mayo Clinic, Rochester, MN
4Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester
5Division of Hematology, Mayo Clinic, Rochester, MN

Sangam Sangam, MD1, Tripti Jain, MD2*, Marco Bermudez, MD3*, Yemesrach Mekonen1*, Francisco Gallegos Koyner, MD3* and Shorabh Sharma, MD1*

1Department of Medicine, SBH Health System, Bronx, NY
2Rochester General Hospital, Rochester, NY
3Department of Medicine, SBH Health System, Bronx

John O. Mascarenhas, MD1, Sebastian Grosicki, MD, PhD2*, Dominik Chraniuk, MD3*, Elisabetta Abruzzese, MD4, Prithviraj Bose, MD5, Aaron T. Gerds, MD, MS6, Alessandro M. Vannucchi, MD, PhD7, Francesca Palandri, MD, PhD8*, Sung-Eun Lee, MD, PhD9*, Vikas Gupta, MD, FRCP, FRCPath10, Alessandro Lucchesi, MD, PhD11*, Stephen Oh, MD, PhD12, Andrew T. Kuykendall, MD13, Andrea Patriarca, MD14*, Alberto Alvarez-Larran15*, Ruben Mesa, MD16*, Jean-Jacques Kiladjian, MD, PhD17, Moshe Talpaz, MD18, Morgan Harris, PharmD19*, Sarah-Katharina Kays, PhD20*, Qing Li, PhD21*, Barbara Brown, PhD19*, Anna-Maria Jegg, PhD20*, Claire Harrison22 and Raajit Rampal, MD, PhD23

1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
2Medical University of Silesia, Katowice, Poland
3Hematology Ward, Wojewódzki Szpital Zespolony im. L. Rydygiera, Torun, Poland
4Department of Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma 2, Roma, I, Italy
5Leukemia Department, University of Texas MD Anderson Cancer Center, Houston, TX
6Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
7Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy
8IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Istituto di Ematologia "Seràgnoli", Bologna, Italy
9Department of Hematology,, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
10The Princess Margaret Cancer Centre, Toronto, ON, Canada
11Hematology Unit, IRCCS Istituto Romagnolo per lo Studio e la Cura dei Tumori (IRST) “Dino Amadori”, Meldola (FC), Italy
12Washington University School of Medicine in St. Louis, St. Louis, MO
13Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
14Hematology Unit, AOU Maggiore della Carità and University of Eastern Piedmont, Novara, Italy
15Hematology Department, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
16Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC
17Clinical Investigation Center, Hôpital Saint-Louis, Université de Paris, Paris, France
18University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
19Constellation Pharmaceuticals, a MorphoSys Company, Boston, MA
20MorphoSys AG, Planegg, Germany
21MorphoSys US Inc, Boston, MA
22Department of Haematology, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
23Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY

Lindsay A.M. Rein, MD1, Firas El Chaer, MD2, Junichiro Yuda, MD, PhD3, Kazuya Shimoda, MD, PhD4, Raajit Rampal, MD, PhD5, Joseph M. Scandura, MD, PhD6, Akiyoshi Takami, MD, PhD7, James McCloskey, MD8, Michiko Ichii, MD, PhD9*, Shuichi Shirane, MD, PhD10*, Alessandra Iurlo, MD, PhD11*, Prithviraj Bose, MD12, Alessandro Lucchesi, MD, PhD13*, Giulia Benevolo, MD14*, Idoroenyi Amanam, MD15, Pankit Vachhani, MD16*, Srinivas K Tantravahi, MD17, Marcello Rotta, MD18*, Yasushi Onishi, MD, PhD19*, Jean-Jacques Kiladjian, MD, PhD20, Ciro Rinaldi, MD, PhD21*, Nikki Granacher, MD22*, Terrence Bradley, MD23, Anand Ashwin Patel, MD24, Michael Loschi, MD, PhD25*, Samah Alimam, MD, PhD26*, Stanley Cheung, MD, PhD27*, Vincent Ribrag, MD28, Sujan Kabir, MD29*, Masataka Seki, MS29*, Karen Ansaldo, PharmD29*, Guia Guffanti, PhD29*, Jinny Lee, PhD29*, Steven L. Warner, PhD29, Jason M. Foulks, PhD29 and Ruben Mesa, MD30*

1Duke University Medical Center, Durham, NC
2University of Virginia Health System, Charlottesville, VA
3National Cancer Center Hospital East, Kashiwa, Japan
4Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, University of Miyazaki, Miyazaki, Japan
5Memorial Sloan Kettering Cancer Center, New York, NY
6Weill Cornell Medicine, New York, NY
7Aichi Medical University School of Medicine, Nagakute, Japan
8John Theurer Cancer Center at Hackensack Meridian Health, Hackensack, NJ
9Osaka University Graduate School of Medicine, Suita, Japan
10Juntendo University School of Medicine, Bunkyo-ku, Japan
11Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
12The University of Texas MD Anderson Cancer Center, Houston, TX
13IRCCS Istituto Romagnolo per lo Studio e la Cura dei Tumori (IRST) “Dino Amadori”, Meldola, Italy
14AOU Città della Salute e della Scienza, Turin, Italy
15City of Hope National Medical Center, Duarte, CA
16University of Alabama at Birmingham, Birmingham, AL
17Huntsman Cancer Institute, Salt lake city, UT
18Colorado Blood Cancer Institute, Denver, CO
19Tohoku University Hospital, Sendai, Japan
20Hopital Saint-Louis, Paris, France
21Pilgrim Hospital Boston, Boston, United Kingdom
22ZNA Middelheim, Antwerp, Belgium
23University of Miami Health System, Miami, FL
24University of Chicago, Chicago, IL
25CHU de Nice - Hôpital L'Archet 1, Nice, France
26University College of London Hospitals NHS Foundation Trust, London, United Kingdom
27ICON Cancer Care, Kurralta Park, Australia
28Institut Gustave Roussy, Villejuif, France
29Sumitomo Pharma America, Inc., Marlborough, MA
30Atrium Health Levine Cancer Institute, Charlotte, NC

Jian Huang, MD, PhD1,2, Bingbing Wen1,3*, Tiejun Gong4*, Hu Zhou5, Lihong Shou6*, Qingchi Liu7*, Feng Zhang8*, Cuicui WU9*, Wei Yang10*, Lidong Zhao11*, Lili Chen, PhD12*, Jian Lu13*, Yile Zhou, MD1,2*, Yi Zhang1,2* and Jie Jin, M.D.2,14

1Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Zhejiang Provincial Clinical Research Center for Hematological disorders, Hangzhou, China
3The second hospital of shenzhen, Shenzhen, China
4Harbin Institute of Hematology and Oncology, Harbin First Hospital, Harbin, China
5Department of Hematology, Henan Provincial Cancer Hospital, Zhengzhou, China
6Department of Hematology, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, China
7The First Hospital of Hebei Medical University, Shijiazhuang, China
8The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China
9Hematology, Yueyang People's Hospital, HUNAN, China
10Department of Hematology, Shengjing Hospital affiliated to China Medical University, Shenyang, China
11The First People’s Hospital of Lianyungang, Lianyungang, Jiangsu, China
12Taizhou First People’s Hospital, Taizhou, China
13Hangzhou Biosun Pharmaceutical Co., LTD, Hangzhou, Zhejiang, China
14Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Dongni Yi, MD1*, Ronald S Go, M.D.2, Gordon J Ruan, M.D.2, N. Nora Bennani, MD2, Mithun V Shah, M.D., Ph.D.2, Karen L Rech, M.D.3*, Aishwarya Ravindran, M.B.B.S.4*, Jay H Ryu, M.D.5*, Robert Vassallo, M.D.5*, Matthew J Koster, M.D.6*, Caroline J Davidge-Pitts, M.B., B.Ch.7*, Lucinda M Gruber, M.D.7*, William Oliver Tobin, M.B., B.Ch., B.A.O., Ph.D.8*, Julio C Sartori Valinotti, M.D.9*, Talal Hilal, MD10, Liuyan Jiang, M.D.11, Muhamad Alhaj Moustafa, M.D., M.S.12, Asra Z. Ahmed, M.D.13, Gaurav Goyal, MD14 and Jithma P Abeykoon, MD2

1Department of Internal Medicine, Mayo Clinic, Rochester, MN
2Division of Hematology, Mayo Clinic, Rochester, MN
3Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
4Department of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, AL
5Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN
6Division of Rheumatology, Mayo Clinic, Rochester, MN
7Division of Endocrinology, Mayo Clinic, Rochester, MN
8Department of Neurology, Mayo Clinic, Rochester, MN
9Department of Dermatology, Mayo Clinic, Rochester, MN
10Division of Hematology, Mayo Clinic, Phoenix, AZ
11Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL
12Division of Hematology, Mayo Clinic, Jacksonville, FL
13Division of Hematology and Medical Oncology, University of Michigan, Ann Arbor, MI
14Division of Hematology and Medical Oncology, University of Alabama at Birmingham, Birmingham, AL

Dandan Yu1*, Hong-Ju Zhang2*, Yanyan Song2*, Yuan Tao2*, Fengyuan Zhou3*, Ziyi Wang3*, Rongfeng Fu, MD4*, Ting Sun4*, Huan Dong4*, Wenjing Gu4*, Renchi Yang4*, Zhijian Xiao, MD5*, Qi Sun6* and Lei Zhang4,7

1Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, AL, China
2State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People’s Republic of China, Tianjin, China
3XY AI Technologies (Su Zhou) Limited, Jiangsu 215422, China, Jiangsu, China
4Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
5Hematologic Pathology Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
6Department of Pathology, Institute Of Hematology & Blood Diseases Hospital, Chinese Academy Of Medical Science & Peking Union Meical College, Beijing, China
7Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, China, Tianjin, China

Yael Kusne, MD, PhD1, Talha Badar, MD2, Terra L. Lasho, PhD3, Ludovica Marando, MD, PhD4, Abhishek A. Mangaonkar, MBBS4, Christy Finke, BS3*, James M. Foran, MD5, Aref Al-Kali, MD4, Hassan B Alkhateeb, MD3*, Naseema Gangat, MBBS3, Jeanne Palmer, MD6, David Viswanatha, MD7, Mark R. Litzow, MD3, Animesh D. Pardanani, MBBS, PhD8, Ayalew Tefferi, MD3, Timothy Chlon, PhD9, Alejandro Ferrer, PhD4 and Mrinal M. Patnaik, MD, MBBS4

1Mayo Clinic, Phoenix, AZ
2Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
3Division of Hematology, Mayo Clinic, Rochester, MN
4Mayo Clinic, Rochester, MN
5Division of Hematology & Medical Oncology, Mayo Clinic, Jacksonville, FL
6Mayo Clinic - Arizona, Scottsdale, AZ
7Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester
8Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
9Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Isabella Diana Hansen1,2*, Morten Kranker Larsen, MSc1,3*, Vibe Skov1*, Lasse Kjær1*, Christina Ellervik3,4,5,6*, Anders Lindholm Sørensen1*, Trine Alma Knudsen1, Sarah Friis Christensen1*, Sabrina Cordua1*, Christina Schjellerup Eickhardt-Dalbøge1*, Troels Wienecke3,7*, Marie Hvelplund Kristiansen7* and Hans C. Hasselbalch1,3*

1Department of Hematology, Zealand University Hospital, Roskilde, Denmark
2Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
3Faculty of Health and Medical Sciences, Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
4Department of Production, Research, and Innovation, Region Zealand, Soroe, Denmark
5Department of Laboratory Medicine, Boston Children's Hospital, Boston, MA
6Department of Pathology, Harvard Medical School, Boston
7Department of Neurology, Zealand University Hospital, Roskilde, Denmark

Naseema Gangat, MBBS1, Giuseppe Gaetano Loscocco2*, Patricia Carey, MD3*, Priyansh Faldu4*, Moazah Iftikhar, MBBS5*, Masooma S Rana, MBBS5*, Yamna Jadoon, MBBS6, Animesh D. Pardanani, MBBS, PhD5, Natasha Szuber, MD, MSc7, Alessandra Carobbio8*, Tiziano Barbui, MD9*, Alessandro Maria Vannucchi10, Ayalew Tefferi, MD1 and Paola Guglielmelli, MD11

1Division of Hematology, Mayo Clinic, Rochester, MN
2Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy
3Mayo Clinic, Rochester, MN
4Mayo Clinic, Rochester
5Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
6UMass Chan Medical School Baystate, Broad Brook, CT
7Institut universitaire d'hématologie-oncologie et de thérapie cellulaire, Université de Montréal, Montreal, QC, Canada
8Fondazione per la Ricerca Ospedale di Bergamo (FROM), Bergamo, Italy
9FROM Research Foundation ASST Papa Giovanni XXIII Bergamo, Bergamo, ITA
10Department of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Firenze, Tuscany, Italy
11Department of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Florence, Italy

Adam J Mead, PhD, MRCP, FRCPath1, Brian J P Huntly, MD2*, Bethan Psaila, MD, PhD3, Claire Harrison4, Rebecca Boucher5*, Jiayi Wang5*, Rebecca Collings5*, Zsofia Nagy5* and Rebecca Record5*

1Medical Research Council (MRC) Weatherall Institute of Molecular Medicine (WIMM), University of Oxford, Oxford, United Kingdom
2Department of Haematology and Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom
3Medical Research Council (MRC) Weatherall Institute of Molecular Medicine (WIMM), University of Oxford, Oxford, ENG, United Kingdom
4Guy's and St Thomas' NHS Foundation Trust, London, ENG, United Kingdom
5University of Birmingham, Birmingham, United Kingdom

Francesca Palandri, MD, PhD1*, Venediktos Kapetanakis2*, Balazs Dobi3*, Filippo Branzanti, MSc4*, Catherine Ellis, BS5*, Nick Ballew, PhD5*, Tom Liu, MS5*, Kelesitse Phiri, ScD5*, Fulya Sen Nikitas6*, Melania Biasi7*, Shiyuan Zhang, MSc5* and Dwaipayan Patnaik, MD, MBBS8

1IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Istituto di Ematologia "Seràgnoli", Bologna, Italy
2Evidera Ltd, London, United Kingdom
3Evidera, Budapest, Hungary
4IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
5GSK plc, Collegeville, PA
6GSK plc, London, United Kingdom
7GSK plc, Verona, Italy
8GSK plc, Baar, Switzerland

Orly Leiva, MD1,2, Steven Soo, M.D.3*, Nathaniel Smilowitz4*, Harmony Reynolds4*, Binita Shah4*, Samuel Bernard4*, Michelle Hyunju Lee, MD5, Chi-Joan How, MD6 and Gabriela S. Hobbs, MD7

1University of Chicago, New York City, NY
2New York University Langone Health, New York City, NY
3New York University Long Island School of Medicine, Mineola, NY
4New York University Grossman School of Medicine, New York City, NY
5Department of Medical Oncology, Massachusetts General Hospital, Winchester, MA
6Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA
7Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA

Arnon Haran1*, Avital Wasserstrom2*, Shlomzion Aumann3*, Vladimir Vainstein, MD4*, Romi Kazoom2*, Batia Roth Jelinek, MD4*, Ariela Arad, MD5*, Noa Buchman, MD4*, Ela Shai, PhD4*, Yossi Kalish, MD5*, Moshe E Gatt, MD6 and Eran Zimran7*

1Department of Hematology, Hadassah Hebrew University Medical Center, Jerusalem, Israel
2Hadassah Hebrew University Medical Center, Jerusalem, Israel
3Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
4Department of Hematology, Hadassah Medical Center, Jerusalem, Israel
5Hematology Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
6Hematology department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
7Hadassah Medical Center, Jerusalem, Israel

Ghaith Abu-Zeinah, MD, Katie Erdos*, Neville Lee Jr.*, Richard T. Silver, MD and Joseph M. Scandura, MD, PhD

Richard T. Silver, MD Myeloproliferative Neoplasms Center, Weill Cornell Medicine, New York, NY

Francesca Palandri, MD, PhD1*, Marta Sobas, MD2*, Claire Harrison3, Raajit Rampal, MD, PhD4, Sarah Buckley, MD5*, Purvi Suthar, PharmD5*, Karisse Roman-Torres5* and John O. Mascarenhas, MD6

1IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia s. Orsola-Malpighi, Bologna, Italy
2Wroclaw Medical University, Wroclaw, Poland
3Guys and St Thomas NHS Trust, London, United Kingdom
4Memorial Sloan Kettering Cancer Center, New York, NY
5Sobi Inc., Waltham, MA
6Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

*signifies non-member of ASH